Acusensus Ltd (ACE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Acusensus Ltd (ACE) has a cash flow conversion efficiency ratio of 0.023x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.29 Million ≈ $911.34K USD) by net assets (AU$56.06 Million ≈ $39.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Acusensus Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Acusensus Ltd - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Acusensus Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Acusensus Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Acusensus Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
IS:ONCSM
|
0.126x |
|
Samick Thk
KO:004380
|
0.064x |
|
ANDREW PELLER LTD A
F:ANJ
|
0.013x |
|
DaeChang Solution Co. Ltd
KQ:096350
|
-0.002x |
|
Dong Hai JSC of Bentre
VN:DHC
|
0.005x |
|
Kotra Industries Bhd
KLSE:0002
|
0.038x |
|
NINtec Systems Limited
NSE:NINSYS
|
0.179x |
|
Ilex Medical
TA:ILX
|
0.068x |
Annual Cash Flow Conversion Efficiency for Acusensus Ltd (2020–2025)
The table below shows the annual cash flow conversion efficiency of Acusensus Ltd from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Acusensus Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$46.79 Million ≈ $33.11 Million |
AU$8.27 Million ≈ $5.85 Million |
0.177x | +77.44% |
| 2024-06-30 | AU$35.92 Million ≈ $25.42 Million |
AU$3.58 Million ≈ $2.53 Million |
0.100x | -15.97% |
| 2023-06-30 | AU$35.92 Million ≈ $25.42 Million |
AU$4.26 Million ≈ $3.01 Million |
0.118x | -60.02% |
| 2022-06-30 | AU$16.76 Million ≈ $11.86 Million |
AU$4.97 Million ≈ $3.52 Million |
0.296x | +546.25% |
| 2021-06-30 | AU$15.07 Million ≈ $10.66 Million |
AU$-1.00 Million ≈ $-708.24K |
-0.066x | +87.52% |
| 2020-06-30 | AU$2.70 Million ≈ $1.91 Million |
AU$-1.44 Million ≈ $-1.02 Million |
-0.532x | -- |
About Acusensus Ltd
Acusensus Limited develops technology that focuses on the detection and the provision of prosecutable evidence of distracted driving, seatbelt compliance, speeding, railway crossing compliance, and monitoring vehicles. The company offers Heads Up solution, which is used to detect and capture prosecutable evidence of illegal mobile phone use, seatbelt non-compliance, and speeding; Heads-Up Real Ti… Read more